352 related articles for article (PubMed ID: 24030420)
1. Comparison of transendocardial and intracoronary CD34+ cell transplantation in patients with nonischemic dilated cardiomyopathy.
Vrtovec B; Poglajen G; Lezaic L; Sever M; Socan A; Domanovic D; Cernelc P; Torre-Amione G; Haddad F; Wu JC
Circulation; 2013 Sep; 128(11 Suppl 1):S42-9. PubMed ID: 24030420
[TBL] [Abstract][Full Text] [Related]
2. Effects of intracoronary CD34+ stem cell transplantation in nonischemic dilated cardiomyopathy patients: 5-year follow-up.
Vrtovec B; Poglajen G; Lezaic L; Sever M; Domanovic D; Cernelc P; Socan A; Schrepfer S; Torre-Amione G; Haddad F; Wu JC
Circ Res; 2013 Jan; 112(1):165-73. PubMed ID: 23065358
[TBL] [Abstract][Full Text] [Related]
3. Effects of transendocardial CD34+ cell transplantation in patients with ischemic cardiomyopathy.
Poglajen G; Sever M; Cukjati M; Cernelc P; Knezevic I; Zemljic G; Haddad F; Wu JC; Vrtovec B
Circ Cardiovasc Interv; 2014 Aug; 7(4):552-9. PubMed ID: 25097199
[TBL] [Abstract][Full Text] [Related]
4. Intracoronary transplantation of CD34(+) cells is associated with improved myocardial perfusion in patients with nonischemic dilated cardiomyopathy.
Lezaic L; Socan A; Poglajen G; Peitl PK; Sever M; Cukjati M; Cernelc P; Wu JC; Haddad F; Vrtovec B
J Card Fail; 2015 Feb; 21(2):145-52. PubMed ID: 25459687
[TBL] [Abstract][Full Text] [Related]
5. Effects of Repetitive Transendocardial CD34
Vrtovec B; Poglajen G; Sever M; Zemljic G; Frljak S; Cerar A; Cukjati M; Jaklic M; Cernelc P; Haddad F; Wu JC
Circ Res; 2018 Jul; 123(3):389-396. PubMed ID: 29880546
[TBL] [Abstract][Full Text] [Related]
6. A pilot trial to assess potential effects of selective intracoronary bone marrow-derived progenitor cell infusion in patients with nonischemic dilated cardiomyopathy: final 1-year results of the transplantation of progenitor cells and functional regeneration enhancement pilot trial in patients with nonischemic dilated cardiomyopathy.
Fischer-Rasokat U; Assmus B; Seeger FH; Honold J; Leistner D; Fichtlscherer S; Schächinger V; Tonn T; Martin H; Dimmeler S; Zeiher AM
Circ Heart Fail; 2009 Sep; 2(5):417-23. PubMed ID: 19808371
[TBL] [Abstract][Full Text] [Related]
7. Efficacy of CD34+ Stem Cell Therapy in Nonischemic Dilated Cardiomyopathy Is Absent in Patients With Diabetes but Preserved in Patients With Insulin Resistance.
Vrtovec B; Sever M; Jensterle M; Poglajen G; Janez A; Kravos N; Zemljic G; Cukjati M; Cernelc P; Haddad F; Wu JC; Jorde UP
Stem Cells Transl Med; 2016 May; 5(5):632-8. PubMed ID: 27025690
[TBL] [Abstract][Full Text] [Related]
8. Transendocardial, autologous bone marrow cell transplantation for severe, chronic ischemic heart failure.
Perin EC; Dohmann HF; Borojevic R; Silva SA; Sousa AL; Mesquita CT; Rossi MI; Carvalho AC; Dutra HS; Dohmann HJ; Silva GV; Belém L; Vivacqua R; Rangel FO; Esporcatte R; Geng YJ; Vaughn WK; Assad JA; Mesquita ET; Willerson JT
Circulation; 2003 May; 107(18):2294-302. PubMed ID: 12707230
[TBL] [Abstract][Full Text] [Related]
9. Electroanatomic Properties of the Myocardium Predict Response to CD34+ Cell Therapy in Patients With Ischemic and Nonischemic Heart Failure.
Zemljic G; Poglajen G; Sever M; Cukjati M; Frljak S; Androcec V; Cernelc P; Haddad F; Vrtovec B
J Card Fail; 2017 Feb; 23(2):153-160. PubMed ID: 27523610
[TBL] [Abstract][Full Text] [Related]
10. The efficacy of bone marrow mononuclear stem cell transplantation in patients with non-ischemic dilated cardiomyopathy-a meta analysis.
Nso N; Bookani KR; Enoru ST; Radparvar F; Gordon R
Heart Fail Rev; 2022 May; 27(3):811-820. PubMed ID: 33587248
[TBL] [Abstract][Full Text] [Related]
11. Pilot study to evaluate the safety and feasibility of intracoronary CD133(+) and CD133(-) CD34(+) cell therapy in patients with nonviable anterior myocardial infarction.
Manginas A; Goussetis E; Koutelou M; Karatasakis G; Peristeri I; Theodorakos A; Leontiadis E; Plessas N; Theodosaki M; Graphakos S; Cokkinos DV
Catheter Cardiovasc Interv; 2007 May; 69(6):773-81. PubMed ID: 17394248
[TBL] [Abstract][Full Text] [Related]
12. [Effects of intracoronary autologous bone marrow mononuclear cells transplantation in patients with dilated cardiomyopathy].
CHEN Y; GAO EM; GAO CY; XU Y; HUANG KJ; NIU ZM; ZHU ZY; YANG HH; LI MW
Zhonghua Xin Xue Guan Bing Za Zhi; 2008 Dec; 36(12):1087-91. PubMed ID: 19134276
[TBL] [Abstract][Full Text] [Related]
13. Effects of Transendocardial CD34
Bervar M; Kozelj M; Poglajen G; Sever M; Zemljic G; Frljak S; Cukjati M; Cernelc P; Haddad F; Vrtovec B
Stem Cells Transl Med; 2017 Jun; 6(6):1515-1521. PubMed ID: 28296283
[TBL] [Abstract][Full Text] [Related]
14. [A prospective, randomized, controlled trial of autologous mesenchymal stem cells transplantation for dilated cardiomyopathy].
Wang JA; Xie XJ; He H; Sun Y; Jiang J; Luo RH; Fan YQ; Dong L
Zhonghua Xin Xue Guan Bing Za Zhi; 2006 Feb; 34(2):107-10. PubMed ID: 16626573
[TBL] [Abstract][Full Text] [Related]
15. Multicentre, randomized, double-blind trial of intracoronary autologous mononuclear bone marrow cell injection in non-ischaemic dilated cardiomyopathy (the dilated cardiomyopathy arm of the MiHeart study).
Martino H; Brofman P; Greco O; Bueno R; Bodanese L; Clausell N; Maldonado JA; Mill J; Braile D; Moraes J; Silva S; Bozza A; Santos B; Campos de Carvalho A;
Eur Heart J; 2015 Nov; 36(42):2898-904. PubMed ID: 26392433
[TBL] [Abstract][Full Text] [Related]
16. CD34
Frljak S; Jaklic M; Zemljic G; Cerar A; Poglajen G; Vrtovec B
Stem Cells Transl Med; 2018 Feb; 7(2):168-172. PubMed ID: 29380563
[TBL] [Abstract][Full Text] [Related]
17. Improved exercise capacity and ischemia 6 and 12 months after transendocardial injection of autologous bone marrow mononuclear cells for ischemic cardiomyopathy.
Perin EC; Dohmann HF; Borojevic R; Silva SA; Sousa AL; Silva GV; Mesquita CT; Belém L; Vaughn WK; Rangel FO; Assad JA; Carvalho AC; Branco RV; Rossi MI; Dohmann HJ; Willerson JT
Circulation; 2004 Sep; 110(11 Suppl 1):II213-8. PubMed ID: 15364865
[TBL] [Abstract][Full Text] [Related]
18. Comparison of Mesenchymal Stem Cell Efficacy in Ischemic Versus Nonischemic Dilated Cardiomyopathy.
Tompkins BA; Rieger AC; Florea V; Banerjee MN; Natsumeda M; Nigh ED; Landin AM; Rodriguez GM; Hatzistergos KE; Schulman IH; Hare JM
J Am Heart Assoc; 2018 Jul; 7(14):. PubMed ID: 30005555
[TBL] [Abstract][Full Text] [Related]
19. Immunologic Network and Response to Intramyocardial CD34+ Stem Cell Therapy in Patients With Dilated Cardiomyopathy.
Haddad F; Sever M; Poglajen G; Lezaic L; Yang P; Maecker H; Davis M; Kuznetsova T; Wu JC; Vrtovec B
J Card Fail; 2015 Jul; 21(7):572-82. PubMed ID: 25863169
[TBL] [Abstract][Full Text] [Related]
20. Effects of adipose tissue-derived stem cell therapy after myocardial infarction: impact of the route of administration.
Rigol M; Solanes N; Farré J; Roura S; Roqué M; Berruezo A; Bellera N; Novensà L; Tamborero D; Prat-Vidal C; Huzman MA; Batlle M; Hoefsloot M; Sitges M; Ramírez J; Dantas AP; Merino A; Sanz G; Brugada J; Bayés-Genís A; Heras M
J Card Fail; 2010 Apr; 16(4):357-66. PubMed ID: 20350704
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
